Loss of Argininosuccinate Synthetase-1 (ASS1) Occurs in Esophageal Adenocarcinoma and Represents a Promising Biomarker for Therapy with Pegargiminase
Karl Knipper(University Hospital Cologne), Alexander Quaas(University of Cologne)
Cited by 0
Related Papers
Optimized PD-L1 scoring of gastric cancer
|Gastric Cancer|2021|78
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma
|Journal of Cancer Research and Clinical Oncology|2020|45
Semaphorin 3F (SEMA3F) influences patient survival in esophageal adenocarcinoma
|Scientific Reports|2024|3